Fourteen patients suffering from actinic prurigo were treated with thalidomide. Eleven patients showed lasting improvement on the drug and three of these remained symptom-free after discontinuing therapy. No major side-effects were observed. Thalidomide is an effective drug in the treatment of actinic prurigo but it must be used with adequate contraception in women of child-bearing age.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2133.1983.tb04601.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring adult-onset actinic prurigo in Thailand.
Dermatol Reports
September 2024
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Article Synopsis
- Actinic prurigo (AP)
- is a rare skin condition primarily affecting adults in Thailand, with a mean onset age of 45.5 years, and is more common in males (66.7%) compared to females.
- Clinical features
- include papules mostly on the face and upper extremities, with some patients experiencing mucositis; phototesting showed varying sensitivity to UVA and UVB light.
- Treatment outcomes
- indicate that 60% of patients received systemic immunosuppressants; while the median time for clinical improvement was about 8.6 months, only a small number achieved complete remission.
Treatment of actinic prurigo with dupilumab in an adolescent.
Int J Dermatol
January 2025
Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
Successful treatment of refractory late-onset actinic prurigo with tofacitinib.
Int J Dermatol
December 2024
Department of Dermatology, Venereology and Leprosy, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
Successful treatment of actinic prurigo with baricitinib in an 8-year-old child: A case report.
Pediatr Dermatol
November 2024
Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Article Synopsis
- - Actinic prurigo is a rare skin condition that causes itchy, raised lesions and is particularly difficult to treat, especially in children.
- - Effective management requires strict sun protection, as symptoms can last for most of the year.
- - A case study of an 8-year-old patient showed quick improvement of symptoms using baricitinib, a medication not commonly used for this condition.
Complete response of actinic prurigo to oral baricitinib.
J Dtsch Dermatol Ges
June 2024
Dermatology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!